Publication

Below are the agenda of the talk. Besides, we have also the background of our speakers. Join us and we shall learn together. Free Registration. Register now via the link: https://labclub.mindray.com The LabClub App now allows you to sign up for future HemaTalk...

The future is Clean, Green and Renewable energy. For the oil majors, it means looking into developing new technologies and moving away from traditional fuel sources as a mean to power our economy. One of the small steps towards the ultimate green energy is to reduce...

Source: https://www.theedgemarkets.com/article/too-early-tell-impact-suez-canal-blockage On 23rd March 2021, the most unexpected happened. One of the world's largest container ships was locked for almost a week after being blown into its banks of the Suez Canal. We...

Below are the videos that you should watch to understand fully about MYA 4 How to use vials and tubes with Mya 4 Did you know Mya 4 gives you a great seal Did you know - It's really easy to set up overhead stirring on Mya 4

Below are the agenda of the talk. Besides, we have also the background of our speakers. Join the webinar by scanning the QR code below or by clicking the link below: https://hematalk.mindray.com

Objectives: Fostering a strong relationship with local partnersAgenda: Virtual meeting on product and company updates Updating all our partners with the changes regarding our companies and principals. Briefing on Cytiva's Whatman target market and application, so that...

Topics on: Diagnostic Center Management - Episode 1 Limited seats left. Register now via the link below. Registration: https://www.mindray.com/en/static/webinar?live=labtalk_ep1

Join us and we shall learn together. Limited seats left. Register now via the QR code or the link below. Below is the agenda of the day. Register by clicking the link below! Registration: https://zoom.us/meeting/register/tJ0tf-ivrjorHdOLZw1u-JIP2JZzUno59FQ5

Proven storage giants In many countries, our freezers have become pivotal in the distribution of the SARS-CoV-2 vaccine. We are proud of our production, which has been able to quickly scale up to the increased demand. The current challenge lies mainly in the...